HCV and lymphoproliferative disorders

被引:0
|
作者
Pozzato, G
Mazzaro, C
Burrone, O
机构
[1] INT CTR GENET ENGN & BIOTECHNOL, TRIESTE, ITALY
[2] PORDENONE GEN HOSP, DIV MED 1, PORDENONE, ITALY
来源
CANCER JOURNAL - FRANCE | 1997年 / 10卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mixed cryoglobulinemia is considered a lymphoproliferative disorder characterized by several clinical symptoms (arthralgias, purpura and weakness) and often by organ involvement. Recently, evidence of hepatitis C virus infection in the majority of these patients has been shown, even in absence of clinical and/or laboratory signs of chronic liver disease, suggesting that this virus could be the main etiologic agent of mixed cryoglobulinemia. Finally, HCV has revealed a lymphotropism both in vitro and in vivo. On the basis of these findings, the systematic identification of HCV in different hematological diseases revealed an increased prevalence of HCV infection in non-Hodgkin's lymphomas, especially in immunocytomas, The present work offers an overview of a large number of experimental and clinical observations supporting the possible involvement of HCV in human lymphoproliferative disease.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 50 条
  • [1] Epidemiology of HCV in chronic hepatitis and in lymphoproliferative disorders
    Persico, M
    DeRenzo, A
    Persico, E
    Panariello, A
    deSeta, M
    Villa, MR
    Palmentieri, B
    Conte, S
    Rotoli, B
    Torella, R
    HEPATOLOGY, 1997, 26 (04) : 1808 - 1808
  • [2] Hepatitis C Virus (HCV)-Related Lymphoproliferative Disorders
    Zignego, Anna Linda
    Giannini, Carlo
    Gragnani, Laura
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 : 63 - 63
  • [3] Hepatitis C virus (HCV) infection and lymphoproliferative disorders
    Libra, M
    Gasparotto, D
    Gloghini, A
    Navolanic, PM
    De Re, V
    Carbone, A
    FRONTIERS IN BIOSCIENCE, 2005, 10 : 2460 - 2471
  • [4] Elevated serum levels of osteopontin in HCV-associated lymphoproliferative disorders
    Libra, M
    Indelicato, M
    De Re, V
    Zignego, AL
    Chiocchetti, A
    Malaponte, G
    Dianzani, U
    Nicoletti, F
    Stivala, F
    McCubrey, JA
    Mazzarino, MC
    CANCER BIOLOGY & THERAPY, 2005, 4 (11) : 1192 - 1194
  • [5] Impact of liver transplantation in HCV-related lymphoproliferative disorders.
    Puliti, S
    Feray, C
    Ferri, C
    Giannelli, F
    Marrocchi, ME
    Filipponi, F
    Samuel, D
    Gentilini, P
    Zignego, AL
    HEPATOLOGY, 1998, 28 (04) : 261A - 261A
  • [6] HCV and lymphoproliferative diseases
    Trepo, C
    Berthillon, P
    Vitvitski, L
    ANNALS OF ONCOLOGY, 1998, 9 (05) : 469 - 470
  • [7] HCV and lymphoproliferative diseases
    Santini, GF
    Giannini, F
    Crovatto, M
    Ceselli, S
    Mazzaro, C
    Donada, C
    Mazzi, G
    Pozzato, G
    Sulfaro, S
    Romanelli, M
    Barbisin, M
    Chiarotto, B
    Invernizzi, F
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 : S51 - S57
  • [8] Involvement of PI3K in HCV-related lymphoproliferative disorders
    Alisi, Anna
    Giannini, Carlo
    Spaziani, Alessandra
    Caini, Patrizio
    Zignego, Anna L.
    Balsano, Clara
    JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 214 (02) : 396 - 404
  • [9] B lymphocyte activation in chronic HCV infection: Implications for autoimmune and lymphoproliferative disorders
    Cerino, A.
    Timo, L.
    Comolli, G.
    Cividini, A.
    Gulminetti, R.
    Barnaba, V.
    Mondelli, M. U.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S163 - S163
  • [10] HCV infection and posttransplant lymphoproliferative disorders (PTLD) after liver transplantation (LT).
    Hézode, C
    Duvoux, C
    Germanidis, G
    Roudot-Thoraval, F
    Cherqui, D
    Pawlotsky, JM
    Dhumeaux, D
    HEPATOLOGY, 1998, 28 (04) : 260A - 260A